The Clínica Universidad de Navarra and the CIMAin partnership with the Navarra Hospital Complex and Navarrabiomed, have organized an informative talk open to the public to present DIANA. It is a collaborative project of research funded by the Government of Navarra that aims to goal implement in the clinical internship sequencing techniques and genomic medicine, necessary for precision medicine. The event will take place on Wednesday, October 3 at 7 p.m. at auditorium of CIMA, with free access until fill in capacity.

According to the latest cancer registry published in Navarra, during the period 2008-2009, 10,316 new cases of tumors were diagnosed in the population of Navarra, of which 8,722 were infiltrating malignant tumors. These data highlight an important public health problem with great repercussions on the health care system.

During the session, examples of applications of NGS technologies in the diagnosis and treatment of cancer patients will be presented. As Dr. Felipe Prósper, coordinator of project explains, "these technologies will make it possible to individualize the diagnosis and thus establish the best treatment for each patient, which will result in a better quality of life and a lower economic cost".

Programme

• 19 h: Institutional opening of the event
  Dr. Jesús San Miguel. Director medical of the Clínica Universidad de Navarra and of the CIMA

• 7.05 p.m.: The Government of Navarra's commitment to personalized medicine
  D. Iosu Ibáñez. Head of the Health Section of research and development+i of the Government of Navarra.

• 19.10 h: General introduction of project DIANA, vision from the Navarra Health System.
  Dr. Felipe Prósper. coordinator of project, Clínica Universidad de Navarra and CIMA, and Dr. Ruth Vera, head of the Medical Oncology Service of the Navarra Hospital Complex (CHN) and researcher manager in Navarrabiomed.

• 19.20 h: Personalized medicine based on genetic diagnosis: lung cancer, hematological cancer and hereditary cancer.
  Dr. Rubén Pío, Dr. María José Calasanz and Dr. Maite Herráiz. Researchers from CIMA, CIMA LAB Diagnostics and Clínica Universidad de Navarra

• 19.40 h: Liquid biopsy: diagnosis, treatment and follow-up of the tumor when no tumor is available.
  Dr. Ana Patiño. Researcher at Clínica Universidad de Navarra and CIMA Lab Diagnostics.

• 19.45 h: Open round of questions